'State-Corporate Facilitated Harms of the Pharmaceutical Industry: A Gendered Perspective'

Research output: Contribution to journalArticle

54 Downloads (Pure)

Abstract

The pharmaceutical industry has long been recognised by criminologists as causing social harms towards individuals and groups, by engaging in unethical and illegal business practices in the pathological pursuit of profit (Braithwaite, 1984/2014; Bakan, 2004). This article argues that the neoliberal state is complicit and contributes to pharmaceutical harms due to its reluctance to effectively prohibit and sanction these (Tombs and Whyte, 2015). Neoliberal national healthcare politics and policies have also created rationale and opportunities for private profit creation by the pharmaceutical industry, and resultant social harms (Harvey, 2005; Dorling, 2014). Using a zemiological approach, this article specifically examines why women as healthcare recipients are disproportionately affected by pharmaceutical harms (Szockyi and Fox, 1996). It argues that women who experience social harms caused by the pharmaceutical industry are perceived primarily in relation to their reproductive and sexualised bodies, resulting in devaluation of their health and obscuring of state-corporate harms caused.
Original languageEnglish
Pages (from-to)89-114
Number of pages25
JournalJustice, Power and Resistance: The Journal of the European Group for The Study of Deviance and Social Control.
Volume3
Issue number1
Early online dateApr 2019
Publication statusPublished - Apr 2019

Keywords

  • Gender
  • Neoliberalism
  • Pharmaceutical Industry
  • Profit
  • State-Facilitated Corporate Harm

Fingerprint Dive into the research topics of ''State-Corporate Facilitated Harms of the Pharmaceutical Industry: A Gendered Perspective''. Together they form a unique fingerprint.

  • Profiles

    No photo of HELEN BAKER

    Dr. HELEN BAKER

    Person: Academic

    Cite this